BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2017-05-15

Name: BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2017-05-15
Creator: BIORESTORATIVE THERAPIES, INC.

What BIORESTORATIVE THERAPIES, INC. reported in its quarterly report filed 2017-05-15 (fiscal Q1 2017): 27 published measures, 53 facts as tagged in accession 0001493152-17-005361.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-05-15
Fiscal period: fiscal Q1 2017
Accession: 0001493152-17-005361 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-03-31	1,480,545	USD
At 2016-12-31	1,580,015	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-03-31	6,202,211	USD
At 2016-12-31	6,580,297	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-03-31	-4,721,666	USD
At 2016-12-31	-5,000,282	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	-2,785,754	USD	90
2016-01-01 to 2016-03-31	-2,487,328	USD	91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	89,865	USD	91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	7,000	USD	90
2016-01-01 to 2016-03-31	9,125	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-03-31	-44,745,552	USD
At 2016-12-31	-41,959,798	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-03-31	463,025	USD
At 2016-12-31	508,594	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	955,393	USD	90
2016-01-01 to 2016-03-31	411,618	USD	91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	-2,489,371	USD	90
2016-01-01 to 2016-03-31	-2,067,134	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-03-31	38,223	USD
At 2016-12-31	73,400	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-03-31	6,059,138	USD
At 2016-12-31	5,844,860	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-03-31	2,284,013	USD
At 2016-12-31	2,283,981	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-03-31	7,000	USD
At 2016-12-31	6,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	2,496,371	USD	90
2016-01-01 to 2016-03-31	2,076,249	USD	91

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	7,000	USD	90
2016-01-01 to 2016-03-31	9,115	USD	91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	805,853	USD	90
2016-01-01 to 2016-03-31	866,044	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-03-31	5,331,047	shares
At 2016-12-31	4,699,035	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-03-31	40,018,555	USD
At 2016-12-31	36,954,817	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-03-31	945,121	USD
At 2016-12-31	963,845	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-03-31	1,670,859	USD
At 2016-12-31	1,574,659	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-03-31	22,366	USD
At 2016-12-31	35,578	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	1,197,313	USD	90
2016-01-01 to 2016-03-31	902,881	USD	91

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	64,293	USD	90
2016-01-01 to 2016-03-31	62,392	USD	91

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	-296,383	USD	90
2016-01-01 to 2016-03-31	-420,194	USD	91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	1,000	USD	90
2016-01-01 to 2016-03-31	-84,375	USD	91

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	15,032	USD	90
2016-01-01 to 2016-03-31	-265,091	USD	91

Inspect the source

Entity: BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
Captured: 2026-09-19T11:18:28.483Z
SEC response SHA-256: fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))